Screener/Healthcare/Biotechnology

IKT

Inhibikase Therapeutics, Inc.NASDAQ
$1.65-0.10 (-5.46%)
$1.33
$2.58
$1.57
$1.73
EPS (TTM)$0.48
P/E Ratio3.43
Dividend Yield
Market Cap$130.6M
Volume5.45M
Prev Close$1.74
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$11.9M$-0.13
Q2 '25$0-$9.9M$-0.11
Q1 '25$0-$13.7M$-0.15
Q4 '24$0-$12.1M$0.87
Q3 '24$0-$5.8M$-0.65
Q2 '24$0-$5.0M$-0.66
Q1 '24$0-$4.6M$-0.73
Q4 '23$1-$4.2M$-0.64-417794000.0%
Get Your Daily Market Recap